Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
-
Corinne Charlier
, Jean-Michel Foidart , François Pitance , Philippe Herman , Ulysse Gaspard , Michel Meurisse and Guy Plomteux
Abstract
The carcinogenic potential of environmental xenoestrogens (i.e., organochlorines) is a matter of controversy. Their pathogenic role as promoters in breast cancer has been previously suggested. In Europe, despite their prohibition since the ’70s, residues persist in soil and rivers resulting in a widespread contamination of the general population. In this study, we have compared the serum levels of p,p'-1,1-dichloro-2, 2-bis (4-chlorophenyl) ethylene (DDE) and hexachlorobenzene (HCB) in 231 women at the time of breast cancer discovery and in 290 age-matched healthy controls. p,p'-DDE was found in 76.2% of cases and in 71.1% of controls but HCB was present only in 12.6% of cases (29 from 231) and in 8.9% of controls (26 from 290). Even if taking all undetectable results (recorded as “0”) into consideration, mean values were significantly different in cases when compared to controls. The serum level of p,p'-DDE was 3.46±3.48 ppb (0.58±0.58 μg/g lipid) in patients and 1.85±2.09 ppb (0.31±0.35 μg/g lipid) in controls (p<0.0001). The HCB serum level was 0.66±1.25 ppb (0.11±0.21 μg/g lipid) in patients and 0.20±1.02 ppb (0.03±0.17 μg/g lipid) in controls (p<0.0001). When considering p,p'-DDE and HCB as binary variables (1 if higher than the limit of quantification, 0 if lower), the presence of both residues was significantly associated with an increased risk of breast cancer development (OR 2.21, 95% CI 1.41–3.48 for p,p'-DDE and OR 4.99, 95% CI 2.95–8.43 for HCB). No excess was observed among parous women or when familial history of breast cancer was considered. In the cancer group, no differences in serum levels of p,p'-DDE or HCB were found in relation with estrogen-receptor (ER) status, Bloom stage or lymph node metastasis, but the HCB level was moderately correlated with tumor size (p=0.026).
Copyright © 2004 by Walter de Gruyter GmbH & Co. KG
Articles in the same Issue
- Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
- Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
- Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
- Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
- Antioxidants in patients with hyperthyroidism
- Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
- Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
- Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
- Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
- Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
- Diagnostic use of cerebral and extracerebral oxysterols
- Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
- The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
- Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
- Testing and validating a homogeneous immunometric assay for interference
- Linearity evaluation of analytical methods that count particles
- Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
- Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
- Distribution of low-density lipoprotein particle size in healthy Korean adult males
- Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
- The phenomenon of regression-toward-the-mean
- Error messages when calculating chi-square statistics with Microsoft EXCEL®
- Meetings and Awards
Articles in the same Issue
- Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives
- Regulation of inflammatory responses by activated protein C: the molecular mechanism(s) and therapeutic implications
- Increased serum maternal levels of the HER2 oncoprotein p105 ectodomain in preeclampsia
- Determination of urinary glyoxal and methylglyoxal by high-performance liquid chromatography
- Antioxidants in patients with hyperthyroidism
- Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
- Autoantibodies against oxidized low-density lipoprotein (ox-LDL) and LDL oxidation status
- Concomitant isolation of protein C inhibitor and unnicked β2-glycoprotein I
- Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis
- Urine albumin excretion in acute ischaemic stroke is related to serum interleukin-6
- Diagnostic use of cerebral and extracerebral oxysterols
- Immunoglobulin G Fcγ receptor expression on polymorphonuclear cells in bronchoalveolar lavage fluid of HIV-infected and HIV-seronegative patients with bacterial pneumonia
- The discordance rate, a new concept for combining diagnostic decisions with analytical performance characteristics. 2. Defining analytical goals applied to the diagnosis of type 2 diabetes by blood glucose concentrations
- Effects of some pre-analytical conditions on the measurement of homocysteine and cysteine in plasma
- Testing and validating a homogeneous immunometric assay for interference
- Linearity evaluation of analytical methods that count particles
- Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk?
- Analytical performance and method comparison study of the total homocysteine fluorescence polarization immunoassay (FPIA) on the AxSYM analyzer
- Distribution of low-density lipoprotein particle size in healthy Korean adult males
- Management of invalid internal controls in the Cobas Amplicor HCV-RNA test using the high-speed centrifugation method
- The phenomenon of regression-toward-the-mean
- Error messages when calculating chi-square statistics with Microsoft EXCEL®
- Meetings and Awards